Britain has long been a leader in genome-sequencing
The pandemic has increased its prowess
IN A VIAL of liquid the size of a fingernail sit 384 genomes. A few days ago, each was inside the membrane of a coronavirus, somewhere in a nasal passage in England. The vial’s contents are placed in a printer-sized box packed with lasers and microscopic glass tubes. In the next 24 hours it will tear them into their component molecules, then reassemble them in such a way as to record their original order. That order is the blueprint that determines the virus’s structure—and whether it will co-exist peacefully with humanity, or cause havoc.
This article appeared in the Britain section of the print edition under the headline “Silver linings playbook”
Britain January 29th 2022
- Boris Johnson, the prime minister who can’t say no
- The Bank of England is determined to prevent a wage-price spiral
- Little sign of compromise over the Northern Ireland protocol
- Britain has long been a leader in genome-sequencing
- Brexit and covid-19 have produced a bigger civil service
- Britain’s newly listed tech firms are taking a beating
- After more than two decades, Britain is finally rid of termites
- Boris Johnson is making boring politics look attractive
From the January 29th 2022 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Britain
Britain’s brokers are diversifying and becoming less British
London’s depleted stockmarket is forcing them to change
What a buzzy startup reveals about Britain’s biotech sector
Lots of clever scientists, not enough business nous
Britain’s government lacks a clear Europe policy
It should be more ambitious over getting closer to the EU
The Rachel Reeves theory of growth
The chancellor says it’s her number-one priority. We ask her what that means for Britain